Gherlin expression in women with polycystic ovary syndrome - a preliminary study

The etiology and pathogenesis of polycystic ovary syndrome (PCOS) is still unknown. Using real-time PCR, we detected that polycystic ovaries showed almost ten times lower expression of ghrelin mRNA than normal ovaries, whereas the mRNA levels in blood cells were similar in both study groups. This suggests that the presence of ghrelin in PCOS and normal ovaries may have an autocrine/paracrine modulatory effect on ovary functions and local significance in the etiology of PCOS.

Ghrelin expression, PCOS

[1] Dunaif A., Givens J.R., Haseltine F., Merriam G.R.: "The Polycystic Ovary Syndrome". Cambridge, MA, Blackwell Scientific, 1992.

[2] Farquhar C.M., Birdsall M, Manning P., Mitchell J.M., France J.T.: "The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women". Aust. NZ J. Obstet. Gyneacol., 1994, 34, 67.

[3] Dong J., Albertini D.F., Nishimori K., Kumar T.R., Lu N., Matzuk M.M.: "Growth differentiation factor-9 is required during early ovarian follliculogenesis". Nature, 1996, 383, 531.

[4] Teixeira Filho FL., Baracat E.C., Lee T.H., Suh C.S., Matsui M et al.: "Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome". J. Clin Endocrinol. and Metab., 2002, 87, 1337.

[5] Heinonen S.,K orhonen S.,H elisalmi S.,K oivunen R.,T apanamen J.S., Laakso M.:'The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome" Fertil. Steril., 2004, 82, 743.

[6] Jansen E., Laven J.S., Dommerholt H.B., Polman J., van Rijt C., van der Hurk C. et al.: "Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients". Mal Endocrinol., 2004, 18, 3050.

[7] Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K.: "Ghrelin is a growth-hormone-releasing acylated peptide from stomach". Nature, 1999, 99, 141.

[8] Karbonits M., Kojima M., Kangawa K., Grossman A.B.: "Presence of ghrelin in normal and adenomatous human pituitary". Endocrine, 2001, 14, 101.

[9] Wierup N.,S vensson H.,M ulder H.,S undler F. et al.: "The ghrelm cell: a novel developmentally regulated islet cell in the human pancreas" Regulatory Peptides, 2002, 107, 63.

[10] Tena-Sempere M., Barreiro M.L., Gonzales L.C.: "Novel expression and functional role of ghrelin in rat testis". Endocrinology, 2002, 143, 717.

[11] Polson D.W., Adams J., Wadsworth J., Franks S.: "Polycystic ovaries - a common finding in normal women". Lancet, 1988, 1, 870.

[12] Horvarh T.L., Diano S., Sotonyi P., Meiman M., Tschop M "Minireview. Ghrelin and the regulation of energy balance - a hypothalamic perspective". Endocrinology, 2001, 142, 4163.

[13] Komer J.,A ronne L.J.: "The emerging science of body weight regulation and its impact on obesity treatment". Clin. Invest., 2003, 111, 565.

[14] Zawadski J.K., Dunaif A.: "Diagnostic criteria for polycysllc ovary syndrome: Towards a rational approach". In: Dunaif A., Givens J.R., Haseltine F.P., Merriam G.R. (eds.), Current Issues in Endocrinology and Metabolism. Polycystic Ovary Syndrome Boston, Blackwell Scientific, 1992, 377.

[15] Wasko R.,K omarowska H.,Wa renik-Szymankiewicz A.,S owinski J.: "Elevated ghrelin plasma levels in patients with polycystic ovary syndrome". Horm. Metab. Res., 2003, 36, 170.

[16] Korbonits M., Bustin S.A., Kojima M., Jordan S., Adams E.F., Lowe D.G. et al.: "The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal pituitary and other neuroendocrine tumors". J. Clin Endocrinol. Metab., 2001, 86, 881.

[17] Morrison T.B., Weis J.J., Wittwer C.T.: "Quantification of lowcopy transcripts by continuous SYBR Green I monitoring during amplification". Biotechniques, 1998, 24, 945.

[18] Ririe K.M., Rasmussen R.P., Witwer C.T.: "Product differentiation by analysis of DNA melting curves during the polymerase chain reaction". Anal. Biochem., 1997, 245, 154.

[19] Schofl C., Hom R., Schill T., Schlosser H.W., Muller M.J., Brabant G.: "Circulating ghrelin levels in patients with polycystic ovary syndrome". J. Clin. Endocrinol. Matab,. 2002, 42, 635.

[20] Orio F. Jr., Luc吐P., Palomba S., Tauchmanova L., Cascella T., Russo T. et al.: "Circulating ghrelin concentrations in polycystic ovary syndrome". J Clin. Endocrinol. Metab., 2003, 88, 942.

[21] Pagotto U., Gambineri A., Vicennati V., Heiman M.L., Tschop M., Pasquali R.: "Plasma ghrelin, obesity, and polycystic ovary syndrome". J Clin. Endocrinol. Metab., 2002, 87, 5625.

[22] Horvath T.L., Diano S., Sotonyi P., Heiman M., Tschop M.: "Mini review: ghrelin and the regulation of energy balance - A hypothalamic perspective". Endocrinology, 2001, 142, 4163.

[23] Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A. et al.: "Ghrelin causes hyperphagia and obesity in rats". Diabetes, 2001, 50, 2540.

[24] Gaytan F., Barreiro M.L., Chopin L.K., Herington A.C., Morales C., Pinilla L. et al.: "Immunolocalization of ghrelin and its Functional receptor, the type 1 a growth hormone secretagogue receptor, in the cystic human ovary". J. Clin. Endocrinol. Metab., 2003, 88, 879.

[25] Caminos J.E., Tena-Sempere M., Gaytan F., Sanchez-Criado J.E., Barreiro M.L., Nogueiras R. et al.: "Expression of ghrelin in the cystic and pregnant rat ovary". Endocrinology, 2003, 14494, 1594.

[26] Date Y., Nakazato M., Hashiguchi S., Dezaki K., Monda! M.S., Hosoda H. et al.: "Ghrelin is present in pancreatic alfa-cells of humans and rats and stimulates insulin secretion". Diabetes, 2002, 5, 124.

[27] Garnbineri A., Pagotto U., Tschop M., Vicennati V., Manicardi E., Garcello A. et al.: "Anti-androgen treatment increeeases circulating ghrelin levels in obese women with polycystic ovary syndrome". J Endocrinol. Invest., 2003, 26, 629.